- Home
- AVX vs ANIK Comparison
AVX vs ANIK Comparison
Compare AVX & ANIK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | AVX | ANIK |
|---|---|---|
| Founded | 2017 | 1983 |
| Country | Canada | United States |
| Employees | N/A | N/A |
| Industry | Metal Fabrications | Medical/Dental Instruments |
| Sector | Industrials | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 119.2M | 136.7M |
| IPO Year | 2021 | 1993 |
Fundamental Metrics
Financial Performance| Metric | AVX | ANIK |
|---|---|---|
| Price | $1.74 | $9.39 |
| Analyst Decision | | Buy |
| Analyst Count | 0 | 1 |
| Target Price | N/A | ★ $16.00 |
| AVG Volume (30 Days) | 132.1K | ★ 172.1K |
| Earning Date | 03-13-2026 | 11-05-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | ★ N/A |
| Revenue | $1,319,011.00 | ★ $112,806,000.00 |
| Revenue This Year | $530,767.50 | N/A |
| Revenue Next Year | N/A | $4.79 |
| P/E Ratio | N/A | N/A |
| Revenue Growth | ★ 8001.54 | 30.55 |
| 52 Week Low | $1.12 | $7.87 |
| 52 Week High | $25.38 | $18.37 |
Technical Indicators
Market Signals| Indicator | AVX | ANIK |
|---|---|---|
| Relative Strength Index (RSI) | N/A | 43.53 |
| Support Level | N/A | $9.37 |
| Resistance Level | N/A | $9.66 |
| Average True Range (ATR) | 0.00 | 0.19 |
| MACD | 0.00 | 0.00 |
| Stochastic Oscillator | 0.00 | 15.69 |
Price Performance
Historical ComparisonAbout AVX Avax One Technology Ltd.
AVAX One Technology Ltd is a public company offering investors regulated access to the Avalanche (AVAX) ecosystem. By integrating the reliability of U.S. capital markets with the growth potential of decentralized finance, it seeks to create a bridge between traditional and digital finance. The company focuses on building a digital-asset treasury, fostering innovation, and investing in decentralized financial technologies that benefit from the Avalanche network.
About ANIK Anika Therapeutics Inc.
Anika Therapeutics Inc is an orthopedic medicines company. It is committed to improving the lives of patients with degenerative orthopedic diseases and traumatic conditions with clinically meaningful therapies. The company focuses on orthopedics, including osteoarthritis pain management, regenerative solutions, soft tissue repair, and bone preserving joint technologies. Geographically, it derives a majority of its revenue from the United States and also has its presence in Europe and Other countries.